CAR T-Cell Therapy: Changing the Treatment Landscape for Hematologic Malignancies

In this engaging online program watch experts discuss emerging strategies and current best practices in CAR T-cell therapy for patients with lymphomas leukemias and myelomas. Download slides with all the key data view the on-demand Webcast and join the discussion with expert-authored commentaries and podcasts.

Share

Program Content

Activities

CAR T-Cell Therapy
CAR T-Cell Therapy: Changing the Treatment Landscape for Hematologic Malignancies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 11, 2021

Expires: February 10, 2022

<i>EP</i>: CAR T-Cell Therapy
ExpressPoints: CAR T-Cell Therapy: Changing the Treatment Landscape for Hematologic Malignancies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2021

Expires: February 17, 2022

Activities

CAR T/NHL Approvals
Expanding Approved CAR T-Cell Therapy Treatment Options for Patients With Lymphoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2021

Expires: March 11, 2022

Activities

<i>Pearls</i>: Myeloma and Toxicities
Podcast Pearls: Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities
Podcast Episodes
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2021

Expires: March 11, 2022

Q&A: Myeloma and Toxicities
Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2021

Expires: March 11, 2022

Q&A: Lymphomas
Expert Answers to HCP Questions on CAR T-Cell Therapies in Lymphoma
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: March 18, 2021

Expires: March 17, 2022

Activities

CAR T-Cell Therapy
CAR T-Cell Therapy: Changing the Treatment Landscape for Hematologic Malignancies
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 29, 2021

Expires: March 28, 2022

Faculty

cover img faculity

Renier J. Brentjens, MD, PhD

Associate Professor
Department of Medicine
Weill Medical College of Cornell University
Associate Professor
Department of Pharmacology
Weill Cornell Graduate School of Medical Sciences
Associate Attending
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Jeremy S. Abramson, MD, MMSc

Director, Center for Lymphoma
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Frederick L. Locke, MD

Co-Leader, Moffitt Immuno-Oncology Program
Vice Chair and Associate Member
Department of Blood and Marrow Transplant and Cellular Immunotherapy
Research Director
Medical Director

Immune Cell Therapy Program
Blood and Marrow Transplant and Cellular Immunotherapy
Moffitt Cancer Center
Tampa, Florida

cover img faculity

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Kite Pharma